Nasdaq · CIK 0001178697
SONM DNA X, Inc.
Insider trading from SEC Form 4. Last filing Feb 10, 2026. Close $3.64 on Oct 9, 2026, +32% from the 52-week low and -78% from the high.
DNA X, Inc. (SONM) has 17 SEC Form 4 filings on file from 7 insiders, the latest filed on Feb 10, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
8 open-market trades have been scored at SONM. The newest: Laurence W Lytton (10% owner) sold $1.3M of stock on Jun 26, 2025, filed Jun 30, 2025, scored 57 (moderate). 6 insiders sold within 14 days of each other around Apr 23, 2025.
SONM closed at $3.64 on Oct 9, 2026, 32% above its 52-week low and 78% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at DNA X, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | Laurence W Lytton owner sell | $1.3M 866,916 shares | -100% | +93% from low-55% from high | |
| 46Moderate | Charles Becher See Remarks sell | $45k 31,326 shares | -33% | +10% from low-62% from high | |
| 46Moderate | James S Cassano director sell | $34k 23,381 shares | -32% | +10% from low-62% from high | |
| 47Moderate | Clayton Crolius Chief Financial Officer sell | $17k 11,634 shares | -27% | +10% from low-62% from high | |
| 46Moderate | Michael C Mulica Acting CEO sell | $40k 27,818 shares | -28% | +10% from low-62% from high | |
| 46Moderate | Jack Steenstra director sell | $34k 23,381 shares | -32% | +10% from low-62% from high | |
| 35Weak | Jeffrey Wang director sell | $6,493 4,478 shares | -17% | +10% from low-62% from high | |
| 15Weak | Michael C Mulica Acting CEO sell | $8,394 2,559 shares | -4% | - |
Transactions
Every row filed, 17 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Michael C Mulica Acting CEO | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 54,071 | Feb 10, 2026 |
| Feb 9, 2026 | Clayton Crolius Chief Financial Officer | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 36,719 | Feb 10, 2026 |
| Jun 26, 2025 | Laurence W Lytton owner | SOpen-market sale Common Stock | -466,402 | $1.50 | $700k | 400,514 | Jun 30, 2025 |
| Jun 30, 2025 | Laurence W Lytton owner | SOpen-market sale Common Stock | -400,514 | $1.39 | $557k | 0 | Jun 30, 2025 |
| Apr 23, 2025 | Jack Steenstra director | SOpen-market sale Common Stock | -23,381 | $1.45 | $34k | 49,139 | Apr 25, 2025 |
| Apr 23, 2025 | Jeffrey Wang director | SOpen-market sale Common Stock | -4,478 | $1.45 | $6,493 | 21,301 | Apr 25, 2025 |
| Apr 23, 2025 | Michael C Mulica Acting CEO | SOpen-market sale Common Stock | -27,818 | $1.45 | $40k | 73,292 | Apr 25, 2025 |
| Apr 23, 2025 | Clayton Crolius Chief Financial Officer | SOpen-market sale Common Stock | -11,634 | $1.45 | $17k | 30,958 | Apr 25, 2025 |
| Apr 23, 2025 | James S Cassano director | SOpen-market sale Common Stock | -23,381 | $1.45 | $34k | 49,126 | Apr 25, 2025 |
| Apr 23, 2025 | Charles Becher See Remarks | SOpen-market sale Common Stock | -31,326 | $1.45 | $45k | 62,668 | Apr 25, 2025 |
| Mar 31, 2025 | James S Cassano director | AGrant or award Common Stock | +46,728 | $0.00 | $0 | 72,507 | Apr 2, 2025 |
| Mar 31, 2025 | Michael C Mulica Acting CEO | AGrant or award Common Stock | +46,728 | $0.00 | $0 | 101,110 | Apr 2, 2025 |
| Mar 31, 2025 | Jack Steenstra director | AGrant or award Common Stock | +46,728 | $0.00 | $0 | 72,520 | Apr 2, 2025 |
| Feb 6, 2025 | Charles Becher See Remarks | AGrant or award Common Stock | +70,671 | $0.00 | $0 | 93,994 | Feb 10, 2025 |
| Feb 6, 2025 | Clayton Crolius Chief Financial Officer | AGrant or award Common Stock | +33,922 | $0.00 | $0 | 42,592 | Feb 10, 2025 |
| Nov 12, 2024 | Michael C Mulica Acting CEO | AGrant or award Common Stock | +14,124 | $0.00 | $0 | 56,941 | Nov 14, 2024 |
| Nov 13, 2024 | Michael C Mulica Acting CEO | SOpen-market sale Common Stock | -2,559 | $3.28 | $8,394 | 54,382 | Nov 14, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Charles BecherSee Remarks
- James S Cassanodirector
- Clayton CroliusChief Financial Officer
- Laurence W Lyttonowner
- Michael C MulicaActing CEO
- Jack Steenstradirector
- Jeffrey Wangdirector
Questions about SONM
Answered from the filings on this page, as of the latest one.
Are insiders buying SONM?
No. In the last 90 days no insider at DNA X, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SONM on the open market?
Laurence W Lytton (10% owner) sold $1.3M of SONM on Jun 26, 2025 and filed the Form 4 on Jun 30, 2025. InsiderTell scored 57 (moderate).
How many insiders file Form 4 at DNA X, Inc.?
7 people have filed a Form 4 at DNA X, Inc., among them Charles Becher (See Remarks), James S Cassano (director), Clayton Crolius (Chief Financial Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.